| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 1,268 | 1,240 | 1,235 | 9,242 | | Cost of Revenue | 1,325 | 2,752 | 8,049 | 4,650 | | | Gross Profit | (57) | (1,512) | (6,814) | 4,592 | | | Operating Expenses | | Research Development | 942 | 1,111 | 1,596 | 1,577 | | Selling General and Administrative | 1,313 | 1,380 | 15,328 | 1,830 | | Non Recurring | (3,289) |
-
| 274 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 977 | (4,003) | (24,012) | 1,185 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (13) | (101) | 33 | 431 | | Earnings Before Interest And Taxes | 964 | (4,104) | (23,979) | 1,616 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 964 | (4,104) | (23,979) | 1,616 | | Income Tax Expense | 3 | (76) | 3,701 | 744 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 961 | (4,028) | (27,680) | 872 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 961 | (4,028) | (27,680) | 872 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $961 | ($4,028) | ($27,680) | $872 |
|
0.49% Nasdaq 
Income Statement
